Ubs Group Ag Bausch Health Companies Inc. Call Options Transaction History

Ubs Group Ag

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$7.77 - $10.61 $68,376 - $93,368	8,800 Added 18.68%	55,900 $593,000
Q4 2023 Feb 09, 2024	BUY	$6.53 - $8.23 $307,563 - $387,633	47,100 New	47,100 $377,000
Q2 2023 Aug 11, 2023	SELL	$5.72 - $8.8 $155,584 - $239,360	-27,200 Reduced 18.48%	120,000 $960,000
Q1 2023 May 12, 2023	BUY	$6.28 - $9.85 $364,868 - $572,285	58,100 Added 65.21%	147,200 $1.19 Million
Q4 2022 Feb 08, 2023	SELL	$6.09 - $7.93 $365,400 - $475,800	-60,000 Reduced 40.24%	89,100 $559,000
Q2 2022 Aug 10, 2022	SELL	$7.06 - $23.63 $5.62 Million - $18.8 Million	-796,300 Reduced 84.23%	149,100 $1.25 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $14.5 Million - $18.7 Million	672,900 Added 246.94%	945,400 $21.6 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $3.54 Million - $4.46 Million	153,870 Added 129.71%	272,500 $7.52 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $89,349 - $150,839	4,730 Added 4.15%	118,630 $3.55 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $72,662 - $89,296	-3,480 Reduced 2.96%	113,900 $2.49 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $25,650 - $33,062	1,250 Added 1.08%	117,380 $2.96 Million
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $2.57 Million - $3.35 Million	-127,250 Reduced 52.28%	116,130 $2.87 Million
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $2.83 Million - $4.54 Million	-160,150 Reduced 39.69%	243,380 $4.5 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $8.33 Million - $10.4 Million	403,530 New	403,530 $10.4 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.